Literature DB >> 22039047

Identification and mechanism of 10-carbon fatty acid as modulating ligand of peroxisome proliferator-activated receptors.

Raghu R V Malapaka1, Sokkean Khoo, Jifeng Zhang, Jang H Choi, X Edward Zhou, Yong Xu, Yinhan Gong, Jun Li, Eu-Leong Yong, Michael J Chalmers, Lin Chang, James H Resau, Patrick R Griffin, Y Eugene Chen, H Eric Xu.   

Abstract

Peroxisome proliferator-activated receptors (PPARα, -β/δ, and -γ) are a subfamily of nuclear receptors that plays key roles in glucose and lipid metabolism. PPARγ is the molecular target of the thiazolidinedione class of antidiabetic drugs that has many side effects. PPARγ is also activated by long chain unsaturated or oxidized/nitrated fatty acids, but its relationship with the medium chain fatty acids remains unclear even though the medium chain triglyceride oils have been used to control weight gain and glycemic index. Here, we show that decanoic acid (DA), a 10-carbon fatty acid and a major component of medium chain triglyceride oils, is a direct ligand of PPARγ. DA binds and partially activates PPARγ without leading to adipogenesis. Crystal structure reveals that DA occupies a novel binding site and only partially stabilizes the AF-2 helix. DA also binds weakly to PPARα and PPARβ/δ. Treatments with DA and its triglyceride form improve glucose sensitivity and lipid profiles without weight gain in diabetic mice. Together, these results suggest that DA is a modulating ligand for PPARs, and the structure can aid in designing better and safer PPARγ-based drugs.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22039047      PMCID: PMC3249069          DOI: 10.1074/jbc.M111.294785

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  51 in total

Review 1.  Combinatorial control of gene expression by nuclear receptors and coregulators.

Authors:  Neil J McKenna; Bert W O'Malley
Journal:  Cell       Date:  2002-02-22       Impact factor: 41.582

Review 2.  Peroxisome proliferator-activated receptors: from genes to physiology.

Authors:  S A Kliewer; H E Xu; M H Lambert; T M Willson
Journal:  Recent Prog Horm Res       Date:  2001

Review 3.  Physiological effects of medium-chain triglycerides: potential agents in the prevention of obesity.

Authors:  Marie-Pierre St-Onge; Peter J H Jones
Journal:  J Nutr       Date:  2002-03       Impact factor: 4.798

4.  Dietary medium-chain triacylglycerols suppress accumulation of body fat in a double-blind, controlled trial in healthy men and women.

Authors:  H Tsuji; M Kasai; H Takeuchi; M Nakamura; M Okazaki; K Kondo
Journal:  J Nutr       Date:  2001-11       Impact factor: 4.798

5.  Structural determinants of ligand binding selectivity between the peroxisome proliferator-activated receptors.

Authors:  H E Xu; M H Lambert; V G Montana; K D Plunket; L B Moore; J L Collins; J A Oplinger; S A Kliewer; R T Gampe; D D McKee; J T Moore; T M Willson
Journal:  Proc Natl Acad Sci U S A       Date:  2001-11-06       Impact factor: 11.205

6.  A peroxisome proliferator-activated receptor gamma ligand inhibits adipocyte differentiation.

Authors:  J L Oberfield; J L Collins; C P Holmes; D M Goreham; J P Cooper; J E Cobb; J M Lenhard; E A Hull-Ryde; C P Mohr; S G Blanchard; D J Parks; L B Moore; J M Lehmann; K Plunket; A B Miller; M V Milburn; S A Kliewer; T M Willson
Journal:  Proc Natl Acad Sci U S A       Date:  1999-05-25       Impact factor: 11.205

7.  Value of VLCD supplementation with medium chain triglycerides.

Authors:  M Krotkiewski
Journal:  Int J Obes Relat Metab Disord       Date:  2001-09

8.  Medium- versus long-chain triglycerides for 27 days increases fat oxidation and energy expenditure without resulting in changes in body composition in overweight women.

Authors:  M-P St-Onge; C Bourque; P J H Jones; R Ross; W E Parsons
Journal:  Int J Obes Relat Metab Disord       Date:  2003-01

9.  Octanoate inhibits triglyceride synthesis in 3T3-L1 and human adipocytes.

Authors:  Wen Guo; Tianguang Lei; Tong Wang; Barbara E Corkey; Jianrong Han
Journal:  J Nutr       Date:  2003-08       Impact factor: 4.798

10.  Medium-chain oil reduces fat mass and down-regulates expression of adipogenic genes in rats.

Authors:  Jianrong Han; James A Hamilton; James L Kirkland; Barbara E Corkey; Wen Guo
Journal:  Obes Res       Date:  2003-06
View more
  41 in total

1.  The natural compound, formononetin, extracted from Astragalus membranaceus increases adipocyte thermogenesis by modulating PPARγ activity.

Authors:  Tao Nie; Shiting Zhao; Liufeng Mao; Yiting Yang; Wei Sun; Xiaoliang Lin; Shuo Liu; Kuai Li; Yirong Sun; Peng Li; Zhiguang Zhou; Shaoqiang Lin; Xiaoyan Hui; Aimin Xu; Chung Wah Ma; Yong Xu; Cunchuan Wang; P Rod Dunbar; Donghai Wu
Journal:  Br J Pharmacol       Date:  2018-03-14       Impact factor: 8.739

Review 2.  Eicosanoids in metabolic syndrome.

Authors:  James P Hardwick; Katie Eckman; Yoon Kwang Lee; Mohamed A Abdelmegeed; Andrew Esterle; William M Chilian; John Y Chiang; Byoung-Joon Song
Journal:  Adv Pharmacol       Date:  2013

Review 3.  Small molecule modulation of nuclear receptor conformational dynamics: implications for function and drug discovery.

Authors:  Douglas J Kojetin; Thomas P Burris
Journal:  Mol Pharmacol       Date:  2012-08-06       Impact factor: 4.436

4.  Synergistic protection against acute flurothyl-induced seizures by adjuvant treatment of the ketogenic diet with the type 2 diabetes drug pioglitazone.

Authors:  Timothy A Simeone; Stephanie A Matthews; Kristina A Simeone
Journal:  Epilepsia       Date:  2017-05-28       Impact factor: 5.864

Review 5.  ROR nuclear receptors: structures, related diseases, and drug discovery.

Authors:  Yan Zhang; Xiao-yu Luo; Dong-hai Wu; Yong Xu
Journal:  Acta Pharmacol Sin       Date:  2014-12-15       Impact factor: 6.150

6.  Regulation of brain PPARgamma2 contributes to ketogenic diet anti-seizure efficacy.

Authors:  Timothy A Simeone; Stephanie A Matthews; Kaeli K Samson; Kristina A Simeone
Journal:  Exp Neurol       Date:  2016-08-12       Impact factor: 5.330

7.  Short-chain fatty acids stimulate angiopoietin-like 4 synthesis in human colon adenocarcinoma cells by activating peroxisome proliferator-activated receptor γ.

Authors:  Sheril Alex; Katja Lange; Tom Amolo; Jeffrey S Grinstead; Anders K Haakonsson; Ewa Szalowska; Arjen Koppen; Karin Mudde; Daniëlle Haenen; Sa'ad Al-Lahham; Han Roelofsen; René Houtman; Bart van der Burg; Susanne Mandrup; Alexandre M J J Bonvin; Eric Kalkhoven; Michael Müller; Guido J Hooiveld; Sander Kersten
Journal:  Mol Cell Biol       Date:  2013-01-22       Impact factor: 4.272

8.  Perfluoroalkyl Acid Binding with Peroxisome Proliferator-Activated Receptors α, γ, and δ, and Fatty Acid Binding Proteins by Equilibrium Dialysis with a Comparison of Methods.

Authors:  Manoochehr Khazaee; Emerson Christie; Weixiao Cheng; Mandy Michalsen; Jennifer Field; Carla Ng
Journal:  Toxics       Date:  2021-02-26

9.  Medium chain fatty acids are selective peroxisome proliferator activated receptor (PPAR) γ activators and pan-PPAR partial agonists.

Authors:  Marcelo Vizoná Liberato; Alessandro S Nascimento; Steven D Ayers; Jean Z Lin; Aleksandra Cvoro; Rodrigo L Silveira; Leandro Martínez; Paulo C T Souza; Daniel Saidemberg; Tuo Deng; Angela Angelica Amato; Marie Togashi; Willa A Hsueh; Kevin Phillips; Mário Sérgio Palma; Francisco A R Neves; Munir S Skaf; Paul Webb; Igor Polikarpov
Journal:  PLoS One       Date:  2012-05-23       Impact factor: 3.240

10.  Inhibitors of Fatty Acid Synthesis Induce PPAR α -Regulated Fatty Acid β -Oxidative Genes: Synergistic Roles of L-FABP and Glucose.

Authors:  Huan Huang; Avery L McIntosh; Gregory G Martin; Anca D Petrescu; Kerstin K Landrock; Danilo Landrock; Ann B Kier; Friedhelm Schroeder
Journal:  PPAR Res       Date:  2013-02-26       Impact factor: 4.964

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.